keyword
https://read.qxmd.com/read/38616042/tissue-specific-inflammation-and-insulin-sensitivity-in-subjects-with-obesity
#21
JOURNAL ARTICLE
S M Oussaada, M Kilicarslan, B A de Weijer, P W Gilijamse, A Şekercan, S Virtue, I M C Janssen, A van de Laar, A Demirkiran, B A van Wagensveld, A P J Houdijk, A Jongejan, P D Moerland, J Verheij, T B Geijtenbeek, V W Bloks, M C de Goffau, J A Romijn, M Nieuwdorp, A Vidal-Puig, K W Ter Horst, M J Serlie
Obesity is associated with low-grade inflammation and insulin resistance (IR). The contribution of adipose tissue (AT) and hepatic inflammation to IR remains unclear. We conducted a study across three cohorts to investigate this relationship. The first cohort consists of six women with normal weight and twenty with obesity. In women with obesity, we found an upregulation of inflammatory markers in subcutaneous and visceral adipose tissue, isolated AT macrophages, and the liver, but no linear correlation with tissue-specific insulin sensitivity...
April 12, 2024: Diabetes Research and Clinical Practice
https://read.qxmd.com/read/38616020/uncommon-dermatologic-manifestation-paronychia-in-a-cat-with-diabetes-mellitus
#22
JOURNAL ARTICLE
Andhika Putra, Curtis Plowgian
A 3.5-year-old male intact domestic short hair cat presented for a chronic wound and crusts over the claw and claw folds over several months. The cat was diagnosed with diabetes mellitus based on the presence of persistent hyperglycemia, glucosuria, and compatible clinical signs which consist of polyuria, polydipsia, polyphagia, and weight loss. Glipizide (Glucotrol XL, Pfizer, Indonesia) 2.5 mg orally twice daily was prescribed. By the seventeenth day, the patient's claws and skin around the paw had normalized and the abnormal claw sloughed off, revealing a normal claw underneath...
April 12, 2024: Topics in Companion Animal Medicine
https://read.qxmd.com/read/38615717/glucagon-based-therapy-for-people-with-diabetes-and-obesity-what-is-the-sweet-spot
#23
JOURNAL ARTICLE
Emma Rose McGlone, Tricia M-M Tan
People with obesity and type 2 diabetes have a high prevalence of metabolic-associated steatotic liver disease, hyperlipidemia and cardiovascular disease. Glucagon increases hepatic glucose production; it also decreases hepatic fat accumulation, improves lipidemia and increases energy expenditure. Pharmaceutical strategies to antagonize the glucagon receptor improve glycemic outcomes in people with diabetes and obesity, but they increase hepatic steatosis and worsen dyslipidemia. Co-agonism of the glucagon and glucagon-like peptide-1 (GLP-1) receptors has emerged as a promising strategy to improve glycemia in people with diabetes and obesity...
April 12, 2024: Peptides
https://read.qxmd.com/read/38614651/management-of-hyperglycaemia-in-people-with-obesity
#24
JOURNAL ARTICLE
Vishnou Mourougavelou, Tahseen A Chowdhury
Diabetes and obesity are closely interlinked. Obesity is a major risk factor for the development of type 2 diabetes mellitus and appears to be an important risk factor for diabetic micro- and macrovascular complications. Management of hyperglycaemia in people with diabetes is important to reduce diabetes-related complications. Previously, there was a significant tension between management of hyperglycaemia and mitigating weight gain. Older drugs, such as sulfonylureas, glitazones, and insulin, although effective antihyperglycaemic agents, tend to induce weight gain...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614648/ehealth-in-obesity-care
#25
JOURNAL ARTICLE
Bukhosi Raymond Sithole, Yannis Pappas, Gurch Randhawa
Obesity in adults is a growing health concern. Although effective, current treatment options have not been able to overcome the various factors that contribute toward rising obesity rates. eHealth might hold the capacity to improve the effectiveness, delivery and flexibility of some of these treatments. Here, we show that eHealth lifestyle change interventions delivered through smartphones (mHealth) can facilitate significant weight loss, making mHealth an attractive adjunct to clinical obesity care. However, evidence is currently limited to short-term effects, and is also lacking with regards to effectiveness based on socioeconomic status and ethnic group...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614647/future-therapies-for-obesity
#26
REVIEW
Eka Melson, Alexander Dimitri Miras, Dimitris Papamargaritis
Obesity is a chronic disease associated with increased morbidity and mortality. Bariatric surgery can lead to sustained long-term weight loss (WL) and improvement in multiple obesity-related complications, but it is not scalable at the population level. Over the past few years, gut hormone-based pharmacotherapies for obesity and type 2 diabetes mellitus (T2DM) have rapidly evolved, and combinations of glucagon-like peptide 1 (GLP1) with other gut hormones (glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin) as dual or triple agonists are under investigation to enhance and complement the effects of GLP1 on WL and obesity-related complications...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614646/the-surgical-management-of-obesity
#27
JOURNAL ARTICLE
Alan Askari, Periyathambi Jambulingam, Roy Gurprashad, Omer Al-Taan, Tanveer Adil, Aruna Munasinghe, Vigyan Jain, Farhan Rashid, Douglas Whitelaw
Obesity has reached pandemic levels globally. Surgical management of obesity aims to establish metabolic control, weight loss and resolution of multiple health conditions and to improve quality of life. Here, we examine the role of surgery in the management of obesity within the context of a multidisciplinary team involving a variety of healthcare professionals. We highlight the importance of patient selection, perioperative care, the various types of bariatric surgery currently available as well as emerging procedures...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614455/the-therapeutic-effect-of-proteinase-activated-receptor-1-antagonist-on-colitis-associated-carcinogenesis
#28
JOURNAL ARTICLE
Xiaodong Li, Lin-Hai Kurahara, Zhixin Zhao, Feiyan Zhao, Ryo Ishikawa, Kiyomi Ohmichi, Gaopeng Li, Tetsuo Yamashita, Takeshi Hashimoto, Mayumi Hirano, Zhihong Sun, Katsuya Hirano
BACKGROUND & AIMS: Inflammatory bowel disease is associated with carcinogenesis, which limits the prognosis of the patients. The local expression of proteinases and proteinase-activated receptor 1 (PAR1 ) increases in the inflammatory bowel disease. The present study investigated the therapeutic effects of PAR1 antagonism on colitis-associated carcinogenesis. METHODS: A colitis-associated carcinogenesis model was prepared in mice by treatment with azoxymethane (AOM) and dextran sulfate sodium (DSS)...
April 11, 2024: Cellular and Molecular Gastroenterology and Hepatology
https://read.qxmd.com/read/38614335/investigation-on-the-interaction-mechanism-during-co-combustion-of-sewage-sludge-and-coal-slime-the-effect-of-coal-slime-type-and-pretreatment-method
#29
JOURNAL ARTICLE
Yanlin Wang, Li Jia, Baihe Guo, Jingkuan Li, Tao Bai, Zhiping Jin, Yan Jin
Co-combustion of sewage sludge (SS) and coal slime (CS) is the preferred method for mitigating their environmental impact and increasing their added value. However, the interaction mechanism between SS and CS during the co-combustion process has not yet developed a unified understanding. This work aims to obtain the effect of CS types on SS-CS co-combustion and reveal the interaction mechanism between SS and CS based on the influence of pretreatment methods on the interaction. The results showed that during co-combustion, SS reduced the ignition and burnout temperatures, and CS with high fixed carbon content (e...
April 11, 2024: Science of the Total Environment
https://read.qxmd.com/read/38614070/thinner-is-better-intentional-weight-loss-and-cardiovascular-risk
#30
JOURNAL ARTICLE
Joseph Abraham, Javed Butler, Stefan D Anker
The relationship between overweight/obesity and cardiovascular events needs to be tackled. The SELECT trial earns praise in showing that using GLP-1 receptor agonists to reduce overweight/obesity itself, in patients without dysglycemia, has beneficial effects on cardiovascular risk factors and clinical outcomes.1 .
April 12, 2024: Med
https://read.qxmd.com/read/38613936/the-red-listed-eagle-owl-bubo-bubo-population-in-norway-is-exposed-to-pop-levels-exceeding-threshold-values-for-adverse-health-effects
#31
JOURNAL ARTICLE
Vidar Torget, Aksel Bernhoft, Mette Hb Müller, Anuschka Polder, Hildegunn Viljugrein, Knut Madslien, Jan Ludvig Lyche
The eagle owl (Bubo bubo) population in Norway is today classified as critically endangered on the red list of endangered species. Because previous studies have detected high concentrations of Persistent Organic Pollutants (POPs) in birds of prey, concerns have been raised whether POPs exposure are a significant factor to the substantial decline of the eagle owl population. The aims of this study were to measure the levels of POPs in eagle owls and to assess whether POPs may represent a potential health risk...
April 10, 2024: Environment International
https://read.qxmd.com/read/38613723/sucralose-c-12-h-19-cl-3-o-8-impact-on-microbial-activity-in-estuarine-and-freshwater-marsh-soils
#32
JOURNAL ARTICLE
Amelia G Westmoreland, Tracey B Schafer, Kendall E Breland, Anna R Beard, Todd Z Osborne
As the general population's diet has shifted to reflect current weight-loss trends, there has been an increase in zero-calorie artificial sweetener usage. Sucralose (C12 H19 Cl3 O8 ), commonly known as Splenda® in the USA, is a primary example of these sweeteners. In recent years, sucralose has been identified as an environmental contaminant that cannot easily be broken down via bacterial decomposition. This study focuses on the impact of sucralose presence on microbial communities in brackish and freshwater systems...
April 13, 2024: Environmental Monitoring and Assessment
https://read.qxmd.com/read/38613667/subcutaneously-administered-tirzepatide-vs-semaglutide-for-adults-with-type-2-diabetes-a-systematic-review-and-network-meta-analysis-of-randomised-controlled-trials
#33
REVIEW
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Athina Stamati, Panagiota Kakotrichi, Aris Liakos, Despoina Vasilakou, Nikolaos Kakaletsis, Apostolos Tsapas, Eleni Bekiari
AIMS/HYPOTHESIS: We conducted a systematic review and network meta-analysis to compare the efficacy and safety of s.c. administered tirzepatide vs s.c. administered semaglutide for adults of both sexes with type 2 diabetes mellitus. METHODS: We searched PubMed and Cochrane up to 11 November 2023 for RCTs with an intervention duration of at least 12 weeks assessing s.c. tirzepatide at maintenance doses of 5 mg, 10 mg or 15 mg once weekly, or s.c. semaglutide at maintenance doses of 0...
April 13, 2024: Diabetologia
https://read.qxmd.com/read/38613489/retrospective-investigation-of-the-energy-requirements-for-weight-loss-and-weight-maintenance-after-weight-loss-programme-in-obese-dogs
#34
JOURNAL ARTICLE
Fabio Alves Teixeira, Vivian Pedrinelli, Mariana Yukari Hayasaki Porsani, Brana Sanctos Alo Bonder, Ana Beatriz Fasolai, Marcio Antonio Brunetto
Obesity is a highly prevalent disease in dogs and is characterized by the excessive accumulation of adipose tissue that results in metabolic changes. Its treatment is based on a negative energy balance focusing on energy restriction. However, there are few studies in dogs that assessed the energy intake needed for adequate weight loss and to weight maintenance afterward. The aim of this study was to evaluate data about the treatment of canine obesity, with emphasis on energy restriction to induce weight loss and to maintain body weight (BW) and ideal body condition after weight loss...
April 13, 2024: Journal of Animal Physiology and Animal Nutrition
https://read.qxmd.com/read/38613178/perceptions-of-an-acceptance-based-weight-management-treatment-among-adults-living-in-rural-areas
#35
JOURNAL ARTICLE
Viviana Bauman, Taylor N Swanson, Abraham J Eastman, Kathryn M Ross, Michael G Perri
Obesity and obesity-related comorbidities disproportionately affect rural communities. Research has emerged in support of a novel acceptance-based behavioural weight management treatment (ABT) that integrates the principles and procedures of acceptance-commitment therapy (ACT) with traditional components of standard behavioural treatment (SBT). The current study assessed the perceptions of community stakeholders in rural areas to session materials of a commercially available ABT program. Surveys and focus groups were used to solicit feedback from three former interventionists with experience delivering SBTs in rural counties and from 17 former participants in these programs...
April 12, 2024: Clinical Obesity
https://read.qxmd.com/read/38613164/chatgpt-gpt-4-large-language-models-opportunities-and-challenges-of-perspective-in-bariatric-healthcare-professionals
#36
JOURNAL ARTICLE
Saikam Law, Brian Oldfield, Wah Yang
ChatGPT/GPT-4 is a conversational large language model (LLM) based on artificial intelligence (AI). The potential application of LLM as a virtual assistant for bariatric healthcare professionals in education and practice may be promising if relevant and valid issues are actively examined and addressed. In general medical terms, it is possible that AI models like ChatGPT/GPT-4 will be deeply integrated into medical scenarios, improving medical efficiency and quality, and allowing doctors more time to communicate with patients and implement personalized health management...
April 12, 2024: Obesity Reviews
https://read.qxmd.com/read/38613109/gut-microbial-dysbiosis-differs-in-two-distinct-cachectic-tumor-bearing-models-consuming-the-same-diet
#37
JOURNAL ARTICLE
Lauri O Byerley, Brittany Lorenzen, Hsiao-Man Chang, William G Hartman, Michael J Keenan, Ryan Page, Meng Luo, Scot E Dowd, Christopher M Taylor
The impact of cancer cachexia on the colonic microbiota is poorly characterized. This study assessed the effect of two cachectic-producing tumor types on the gut microbiota to determine if a similar dysbiosis could be found. In addition, it was determined if a diet containing an immunonutrient-rich food (walnuts) known to promote the growth of probiotic bacteria in the colon could alter the dysbiosis and slow cachexia. Male Fisher 344 rats were randomly assigned to a semi-purified diet with or without walnuts...
April 6, 2024: Nutrients
https://read.qxmd.com/read/38613104/influence-of-bariatric-surgery-on-gut-microbiota-composition-and-its-implication-on-brain-and-peripheral-targets
#38
REVIEW
Sevag Hamamah, Andras Hajnal, Mihai Covasa
Obesity remains a significant global health challenge, with bariatric surgery remaining as one of the most effective treatments for severe obesity and its related comorbidities. This review highlights the multifaceted impact of bariatric surgery beyond mere physical restriction or nutrient malabsorption, underscoring the importance of the gut microbiome and neurohormonal signals in mediating the profound effects on weight loss and behavior modification. The various bariatric surgery procedures, such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), act through distinct mechanisms to alter the gut microbiome, subsequently impacting metabolic health, energy balance, and food reward behaviors...
April 5, 2024: Nutrients
https://read.qxmd.com/read/38613100/predictors-of-mental-health-outcomes-in-a-multidisciplinary-weight-management-program-for-class-3-obesity
#39
JOURNAL ARTICLE
Ashley Lam, Milan K Piya, Nasim Foroughi, Mohammed Mohsin, Ritesh Chimoriya, Nic Kormas, Janet Conti, Phillipa Hay
This study aimed to examine the potential predictors of improvement in mental health outcomes following participation in an intensive non-surgical outpatient weight management program (WMP) in an Australian public hospital. This was a retrospective cohort study of all adults with Class 3 obesity (BMI ≥ 40 kg/m2 ) who enrolled in the WMP from March 2018 to June 2021. The participants completed the Eating Disorder Examination Questionnaire Short Version (EDE-QS), Kessler-10 Psychological Distress Scale, and 36-Item Short-Form Survey (SF-36) at baseline and 12-month follow-up...
April 5, 2024: Nutrients
https://read.qxmd.com/read/38613089/improvement-in-visceral-adipose-tissue-and-ldl-cholesterol-by-high-pufa-intake-1-year-results-of-the-nutriact-trial
#40
JOURNAL ARTICLE
Nina Marie Tosca Meyer, Anne Pohrt, Charlotte Wernicke, Laura Pletsch-Borba, Konstantina Apostolopoulou, Linus Haberbosch, Jürgen Machann, Andreas F H Pfeiffer, Joachim Spranger, Knut Mai
We assessed the effect of a dietary pattern rich in unsaturated fatty acids (UFA), protein and fibers, without emphasizing energy restriction, on visceral adipose tissue (VAT) and cardiometabolic risk profile. Within the 36-months randomized controlled NutriAct trial, we randomly assigned 502 participants (50-80 years) to an intervention or control group (IG, CG). The dietary pattern of the IG includes high intake of mono-/polyunsaturated fatty acids (MUFA/PUFA 15-20% E/10-15% E), predominantly plant protein (15-25% E) and fiber (≥30 g/day)...
April 4, 2024: Nutrients
keyword
keyword
27750
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.